A Study of Lebrikizumab in Patients With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and A Second Controller Medication (VERSE)
Clinical trial NCT01545453 · COMPLETED
Trial details
- NCT number
- NCT01545453
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-03-01
- Primary completion
- 2013-07-01
- Enrollment
- 205
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.